Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation*
暂无分享,去创建一个
A. Prat | N. Seidah | J. Hamelin | S. Nimesh | R. Essalmani | Delia Susan-Resiga | M. Asselin | Jianbing Zhang | K. Wycoff | Elodie Weider | Y. Ashraf